Modelled DT Structure
Method: homology modeling
Template PDB: 6M17_A
Identity: 46.01%
Minimized Score: -1377.55 kcal/mol
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0453 | ||||
Gene Name | SLC6A20 | ||||
Protein Name | Sodium/imino-acid transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 6M17_A Identity: 46.01% Minimized Score: -1377.55 kcal/mol Detail: Structure Info |
||||
Synonyms | SIT1; SLC6A20; Sodium- and chloride-dependent transporter XTRP3; Solute carrier family 6 member 20; Transporter rB21A homolog; XT3; XTRP3 | ||||
DT Family | Neurotransmitter:Sodium Symporter (NSS) Family ; | ||||
Tissue Specificity | Kidney and small intestine. Expressed in theS3 segment of the proximal tubule. | ||||
Function | This transporter mediates the calcium-dependent uptake of imino acids such as L-proline, N-methyl-L-proline and pipecolate as well as N-methylated amino acids. Involved in the transport of glycine. | ||||
Endogenous Substrate(s) | Cl-; Na+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
(γ) Outward/inward-facing Conformation |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(α) Genetic Polymorphisms of This DT |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 1 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Amino acids
|
Approved | Drug Info | Nutritional deficiency | 5B7Z | [1] |
Endogenous Metabolites (EMs) Handled by This DT |
|||||
Endogenous Metabolites (EMs) |
Click to Show/Hide the Full List of EMs: 3 EMs in Total | ||||
EM Name | PubChem CID | Detail | Experimental Material | Ref | |
Glycine betaine | EM Info | Unclear experiment used for identifying this EM | [2] | ||
L-pipecolic acid | EM Info | Unclear experiment used for identifying this EM | [2] | ||
L-proline | EM Info | Unclear experiment used for identifying this EM | [2] | ||
References | |||||
1 | The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2). Biochem J. 2006 Jan 1;393(Pt 1):421-30. | ||||
2 | Metabolomics reveals attenuation of the SLC6A20 kidney transporter in nonhuman primate and mouse models of type 2 diabetes mellitus. J Biol Chem. 2011 Jun 3;286(22):19511-22. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.